E-prescribing Market (2026 - 2033)

E-prescribing Market Summary

The global e-prescribing market size was valued at USD 5.9 billion in 2025 and is projected to grow from USD 7.3 billion in 2026 to USD 27.6 billion by 2033, at a CAGR of 21.0% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 43.2% in 2025. This growth is attributed to government initiatives and regulatory mandates supporting electronic prescribing, the growing adoption of electronic health records (EHRs) and healthcare IT systems, and the expansion of telehealth and remote healthcare services, which are key drivers of the market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

To learn more about this report, Download Free Sample Report

Market Dynamics

The e-prescribing industry is driven by government initiatives and regulatory mandates supporting electronic prescribing, the growing adoption of electronic health records (EHRs) and healthcare IT systems, and the expansion of telehealth and remote healthcare services. Healthcare providers are increasingly adopting e-prescribing solutions to improve prescribing accuracy, enhance workflow efficiency, reduce medication errors, and ensure regulatory compliance.

In addition, advancements in digital health technologies, including cloud-based platforms, clinical decision support, and interoperability with EHRs, pharmacy systems, and health information exchanges, are improving prescription management and care coordination. The increasing focus on patient safety, healthcare cost reduction, and streamlined clinical workflows is further supporting the adoption of e-prescribing across healthcare settings.

Market Characteristics & Concentration

The degree of innovation in the e-prescribing industry is high, driven by advancements in AI, cloud-based healthcare platforms, clinical decision support, and interoperability technologies. For instance, in February 2025, Surescripts launched its Prior Authorization Automation solution, a first-of-its-kind technology that automates prior authorization workflows between healthcare providers and payers. The solution reduces manual administrative tasks, accelerates access to medication, and improves prescribing efficiency by integrating directly into existing clinical workflows.

To learn more about this report, Download Free Sample Report

"Our focus is to make generative AI practical within clinicians' everyday workflows so they can spend more time caring for patients and less time navigating technology."

Seth Howard, Executive Vice President of R&D, Epic Systems Corporation.

The level of partnerships and collaboration activities in the e-prescribing industry is high. For instance, in July 2025, Hackensack Meridian Health partnered with DrFirst to integrate AI-powered medication management tools into its Epic EHR system. The collaboration enables clinicians to access medication history, prescription price transparency, electronic prior authorization, and e-prescribing capabilities within a unified workflow, improving prescribing efficiency and patient care.

"This isn't about using technology for technology's sake. It's about giving our clinicians better tools to help patients receive the right medications quickly, safely, and with less administrative burden."

-Robert C. Garrett, FACHE, Chief Executive Officer, Hackensack Meridian Health.

Regulations significantly affect the e-prescribing industry as governments continue to strengthen policies promoting secure electronic prescribing, interoperability, and patient data protection. Regulations related to Electronic Prescribing of Controlled Substances, HIPAA, GDPR, and national digital health initiatives require solution providers to implement robust security, authentication, and data privacy measures. These regulatory frameworks encourage the adoption of standardized, secure e-prescribing solutions, improving prescription accuracy, reducing fraud, and supporting healthcare interoperability.

The market is expanding as companies strengthen their presence through cloud-based healthcare platforms, strategic acquisitions, and the expansion of digital health infrastructure across developed and emerging markets. Vendors are increasing investments in localized healthcare IT solutions, interoperable EHR platforms, and pharmacy connectivity to improve access to electronic prescribing services.

Analyst Perspective

The e-prescribing market is evolving beyond basic electronic prescription generation toward integrated, workflow-oriented solutions that connect prescribing with patient records, scheduling, payments, clinical documentation, and other healthcare functions. The launch of Boulevard’s ePrescribe functionality reflects this broader shift, particularly in med spas and clinical wellness practices, where providers increasingly seek unified platforms to streamline clinical and administrative workflows. Integration of prescribing capabilities within broader healthcare software ecosystems can reduce system switching, minimize duplicate data entry, and improve workflow efficiency. Going forward, continued integration with electronic health records, clinical decision-support tools, pharmacy networks, and patient-management platforms is expected to strengthen the role of e-prescribing as a core component of connected healthcare delivery.

Product Insights

The solutions segment dominated the market with the largest revenue share of 56.9% in 2025. Increasing adoption of integrated e-prescribing platforms, growing digitalization of healthcare, and the high value of software licensing and subscription models. The segment is further divided into integrated solutions and standalone solutions. Integrated solutions seamlessly connect with electronic health records, electronic medical records, and practice management systems, while standalone solutions are designed to support specific prescribing functions, making them suitable for smaller healthcare providers and independent practices.

The services segment is anticipated to grow at the fastest CAGR of 23.4% over the forecast period. Rising demand for implementation, technical support, training, consulting, and network connectivity services is driving growth in the segment. As healthcare organizations continue adopting cloud-based e-prescribing platforms and interoperable healthcare IT systems, the need for ongoing support and integration services is expected to increase. Among service offerings, support services are projected to account for the largest share due to their role in ensuring uninterrupted system performance and regulatory compliance.

Delivery Mode Insights

The web/cloud-based segment accounted for the largest market revenue share of 62.9% in 2025, owing to its lower implementation costs, scalability, ease of deployment, and remote accessibility. Cloud-based platforms are particularly attractive to physician offices, ambulatory care centers, and small- to medium-sized healthcare organizations seeking cost-effective digital prescribing solutions. Leading healthcare IT companies such as Oracle Health, athenahealth, Veradigm, and eClinicalWorks continue to expand their cloud-based offerings.

The on-premises segment is expected to grow at the fastest CAGR from 2026 to 2033. Large hospitals and integrated healthcare systems continue to prefer on-premise deployments due to enhanced control over sensitive patient data, stronger internal security policies, and customization capabilities. Growing investments in cybersecurity and healthcare IT infrastructure are further supporting demand for on-premise solutions.

End-use Insights

The hospitals segment led the market with the largest revenue share of 37.8% in 2025. This is due to the widespread implementation of enterprise EHR systems, increasing patient volumes, and growing adoption of integrated digital prescribing workflows. Hospitals also benefit from centralized IT infrastructure and regulatory compliance programs, which support the large-scale deployment of e-prescribing systems.

The pharmacy segment is anticipated to grow at the fastest CAGR during the forecast period. Increasing adoption of electronic prescription processing, prescription refill automation, and real-time prescription benefit verification is improving operational efficiency and medication adherence. Integration with e-prescribing networks is further streamlining pharmacy workflows and enhancing patient convenience.

Usage Methods Insights

The handheld segment accounted for the largest market revenue share in 2025, driven by the growing use of smartphones and tablets among healthcare professionals. Mobile e-prescribing applications enable clinicians to securely access medication history, formularies, clinical decision support, and patient information from virtually any location, improving workflow flexibility.

The computer-based devices segment is expected to grow at the fastest CAGR during the forecast period. Desktop and laptop-based e-prescribing systems remain widely used across hospitals and physician practices due to their integration with EHR platforms, advanced clinical workflows, and secure connectivity with pharmacies and healthcare networks.

Substances Insights

The controlled substances segment accounted for the largest market revenue share in 2025, due to increasing adoption of Electronic Prescribing of Controlled Substances and growing regulatory requirements aimed at preventing prescription fraud, medication misuse, and opioid abuse. Secure authentication, identity verification, and audit capabilities are further driving adoption in this segment.

The non-controlled substances segment is anticipated to grow at the fastest CAGR of 28.6% from 2026 to 2033. Rising prescription volumes for chronic diseases such as diabetes, hypertension, cardiovascular disorders, and infectious diseases, along with increasing digitalization of prescribing workflows across primary care and specialty practices, are expected to support continued growth in this segment.

Specialties Insights

The sports medicine segment led the market with the largest revenue share of 23.3% in 2025. This dominance is attributed to the increasing adoption of e-prescribing solutions in outpatient sports medicine clinics and orthopedic practices to streamline medication management, improve prescribing accuracy, and enhance clinical workflow efficiency. The growing volume of sports-related injuries and musculoskeletal disorders has further contributed to the widespread use of electronic prescribing in this specialty.

To learn more about this report, Download Free Sample Report

The cardiology segment is anticipated to grow at the fastest CAGR during the forecast period from 2026 to 2033. The increasing prevalence of cardiovascular diseases, rising demand for long-term medication management, and growing adoption of digital healthcare technologies are driving segment growth. E-prescribing solutions enable cardiologists to improve prescription accuracy, monitor medication histories, support clinical decision-making, and enhance patient adherence, making them an essential component of cardiovascular care.

Regional Insights

The North America e-prescribing market held the largest revenue share of 43.2% in 2025. This dominance is due to advanced healthcare infrastructure, high adoption of digital health technologies, and supportive government regulations. Widespread integration of electronic health records, robust IT systems, and the presence of major solution providers facilitate seamless implementation of e-prescribing solutions. In addition, initiatives such as the U.S. Centers for Medicare & Medicaid Services (CMS) promoting electronic prescribing of controlled substances, rising focus on reducing medication errors, and growing demand for efficient healthcare workflows further drive the region’s dominance in the market.

To learn more about this report, Download Free Sample Report

U.S. E-prescribing Market Trends

The e-prescribing market in the U.S. accounted for the largest market revenue share in North America in 2025, due to the high adoption of EHR systems, favorable federal regulations supporting EPCS, and the increasing use of digital health technologies across hospitals, physician practices, and pharmacies. Growing investments in AI-enabled clinical decision support, interoperability, and cloud-based healthcare platforms are further accelerating the adoption of e-prescribing solutions.

Europe E-Prescribing Market Trends

The e-prescribing market in Europe is driven by increasing healthcare digitalization, expanding adoption of electronic health records, and government initiatives promoting cross-border interoperability and digital prescriptions. Growing investments in healthcare IT infrastructure and rising demand for efficient medication management are supporting market growth across the region.

The UK e-prescribing market is driven by NHS initiatives promoting electronic prescribing and digital healthcare transformation. Increasing adoption of integrated care systems, electronic patient records, and telehealth services is supporting the widespread implementation of e-prescribing across primary and secondary care settings.

The e-prescribing market in Germany is expanding due to increasing implementation of electronic prescriptions (eRezept), growing adoption of healthcare IT solutions, and government initiatives supporting healthcare digitalization. Rising investments in interoperable healthcare systems are further driving market growth.

Asia Pacific E-prescribing Market Trends

The e-prescribing market in the Asia Pacific is expected to grow at the fastest CAGR of 30.3% during the forecast period from 2026 to 2033. Market growth is driven by expanding healthcare digitalization, increasing adoption of EHR systems, improving healthcare infrastructure, and government initiatives promoting digital health services. Growing investments in healthcare IT and telemedicine are further supporting the adoption of e-prescribing solutions.

The Japan e-prescribing market is experiencing significant growth, driven by increasing healthcare digitalization, rapid adoption of electronic medical records, and government initiatives promoting digital healthcare services. The country's aging population and focus on improving medication safety are encouraging greater adoption of e-prescribing solutions.

The e-prescribing market in China is expanding rapidly due to increasing investments in digital healthcare infrastructure, growing adoption of hospital information systems, and the rapid digital transformation of the healthcare sector. The expansion of internet hospitals, electronic health records, and telemedicine services is further accelerating the adoption of e-prescribing solutions across the country.

Latin America E-prescribing Market Trends

The e-prescribing market in Latin America is driven by increasing healthcare digitalization, expanding adoption of electronic medical records, and government efforts to modernize healthcare systems. Rising investments in healthcare IT infrastructure are supporting the implementation of e-prescribing solutions across the region.

Middle East & Africa E-prescribing Market Trends

The e-prescribing market in the Middle East & Africa is witnessing steady growth due to increasing healthcare modernization initiatives, expanding digital health infrastructure, and growing adoption of electronic medical records. Government investments in healthcare digital transformation and improving access to healthcare services are creating new opportunitiesfor the adoption of e-prescribing solutions.

Key E-prescribing Company Insights

Key industry players are continuously innovating and introducing AI-enabled e-prescribing solutions, cloud-based platforms, and interoperable healthcare IT technologies to strengthen their market position. Companies are focusing on integrating e-prescribing with EHRs, pharmacy systems, and clinical decision support tools to improve prescribing efficiency and patient safety. Strategic initiatives such as product launches, partnerships, acquisitions, and geographic expansion are further enhancing their market presence.

Key E-prescribing Companies:

The following key companies have been profiled for this study on the global e-prescribing market:

• Oracle

• Veradigm LLC

• Epic Systems Corporation

• athenahealth

• NextGen Healthcare

• Surescripts

• DrFirst

• eClinicalWorks

• Greenway Health

• Practice Fusion

• RXNT

• MEDITECH

• CompuGroup Medical (CGM)

• AdvancedMD

Recent Developments:

• In July 2026, LENZ Therapeutics launched a new telehealth prescribing platform for VIZZ (aceclidine ophthalmic solution) 1.44%, enabling eligible patients to receive online evaluations from independent licensed eye care providers, electronic prescription fulfillment through an e-pharmacy partner, and home delivery. The initiative is designed to improve patient access, streamline the e-prescribing process, and accelerate the adoption of VIZZ for the treatment of presbyopia.

"At this stage of our launch, our goal is to make accessing VIZZ as seamless as possible. With the launch of this platform, we are removing a key hurdle to product access by providing consumers with a safe and convenient way to be evaluated online by an independent, licensed eye care professional who can determine whether VIZZ may be appropriate for them. We believe the combination of introducing telehealth and our national television advertising campaign will help accelerate consumer awareness, access, and adoption of VIZZ."

Eef Schimmelpennink, President and Chief Executive Officer, LENZ Therapeutics.

• In April 2026, Boulevard announced the launch of ePrescribe, a new functionality that enables secure electronic prescribing directly within patient profiles. By integrating prescribing into the existing workflow, ePrescribe is designed to reduce the need to switch between systems, minimize duplicate data entry, and reduce the potential for prescription-related errors. The feature allows med spas and other clinical wellness practices to manage prescriptions alongside payments, scheduling, charting, and other patient-related workflows within the Boulevard platform.

Global E-prescribing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global e-prescribingmarket report based on the product, delivery mode, end-use, usage method, substance, specialties, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Solutions

    • Integrated Solutions

    • Standalone Solutions

  • Services

    • Support

    • Implementation

    • Training

    • Network

• Delivery Mode Outlook (Revenue, USD Billion, 2021 - 2033)

  • Web/Cloud-Based

  • On Premise

• End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospital

  • Office-based Physicians

  • Pharmacy

• Usage Methods Outlook (Revenue, USD Billion, 2021 - 2033)

  • Handheld

  • Computer-Based Devices

• Substances Outlook (Revenue, USD Billion, 2021 - 2033)

  • Controlled Substances

  • Non-controlled Substances

• Specialties Outlook (Revenue, USD Billion, 2021 - 2033)

  • Oncology

  • Sports Medicine

  • Neurology

  • Cardiology

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The e-prescribing marketfigures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing—reconciling supply-side and demand-side estimates—and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each e-prescribing segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations